Below is the latest Dana email newsletter. You can sign up to receive this (and other Dana email alerts and/or print publications) by going here.
by Eric J. Nestler, M.D., Ph.D.
A growing number of provocative demonstrations suggest that behavioral exposures can be passed onto offspring. One of our series of Reports on Progress.
Researchers are discovering medicines and methods that could enhance, dampen, or erase memories. At the recent BNA Festival of Neuroscience, ethicists and scientists considered the implications of modifying the mental record during a process called memory reconsolidation.
Researchers and device-makers seek to quickly put their discoveries to use in a way that patients will prefer. “You can have the best technology but if the patient doesn’t want to use it or wear it, it all ends there.” See also: Report on Progress: For Brain-Machine Interfaces, A multi-disciplinary approach shows progress
At a recent New York Academy of Sciences meeting, researchers presented data suggesting that targeting glutamate in the brain could help people who don’t respond to current therapies.
The brain can regain language abilities even years after a stroke — and training the toughest language tasks, not the easiest, first may be the best recovery strategy.
The process of developing effective therapies for Alzheimer’s disease must be simplified, or else pharmaceutical companies are likely to take their money elsewhere, says Guy McKhann, professor of neurology and neuroscience at Johns Hopkins University.
For some people, trying LSD or Ecstacy (MDMA) can leave a legacy of chronic visual hallucinations.